tiprankstipranks
Hisamitsu Pharmaceutical Co (HTSUF)
:HTSUF
US Market
Holding HTSUF?
Track your performance easily

Hisamitsu Pharmaceutical Co (HTSUF) Financial Statements

5 Followers

Hisamitsu Pharmaceutical Co Financial Overview

Hisamitsu Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $1.386; its P/E ratio is ―; and it has a dividend yield of 1.96%. Hisamitsu Pharmaceutical Co is scheduled to report earnings on April 10, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 22Aug 22May 22Feb 22Nov 21
Income Statement-
Total Revenue$ 32.26B$ 33.23B$ 26.39B$ 33.53B$ 28.11B
Gross Profit$ 18.32B$ 19.72B$ 14.74B$ 18.29B$ 16.35B
EBIT$ 4.10B$ 6.54B$ 2.40B$ 3.97B$ 1.83B
EBITDA$ 4.10B$ 6.54B$ 2.40B$ 3.97B$ 1.83B
Net Income Common Stockholders$ 3.02B$ 4.87B$ 1.63B$ 3.44B$ 1.22B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 149.50B$ 151.32B$ 142.11B$ 142.43B$ 143.01B
Total Assets$ 336.88B$ 327.90B$ 307.76B$ 302.86B$ 304.00B
Total Debt$ 1.24B$ 1.25B$ 1.27B$ 2.46B$ 1.35B
Net Debt$ -148.26B$ -150.06B$ -140.83B$ -139.97B$ -141.67B
Total Liabilities$ 65.06B$ 61.62B$ 56.05B$ 47.98B$ 50.09B
Stockholders Equity$ 269.75B$ 264.32B$ 249.86B$ 253.16B$ 252.21B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Hisamitsu Pharmaceutical Co Earnings and Revenue History

Hisamitsu Pharmaceutical Co Debt to Assets

Hisamitsu Pharmaceutical Co Cash Flow

Hisamitsu Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis